top of page

Proven Regenerative Medicine Leader

Double doctorates:

Harvard medical sciences and periodontal medicine.

 

Vanderbilt University Medical Center (VUMC) & Nashville Biosciences (NB):

Founding member Board of Directors of independent VUMC & NB

Chair of Audit and Compliance Committee - VUMC (5 years)

Chair of Compensation and Leadership Committee - VUMC (3 years)

​

Internationally recognized expert in regenerative medicine:

>200 patents and publications

Hundreds of invited lectures in 25+ countries

​

3-time Founder & CEO (all highly successful exists):

Osteohealth Co. 

  • Now a division of Geistlich Pharma

BioMimetic Therapeutics [Nasdaq: BMTI]

  • IPO then trade sale, Now a division of Stryker, Inc.​

Lynch Biologics, LLC.​

  • Private sale to Geistlich Pharma NA for undisclosed amount​​​​​​

​

Southeast Medical Device Association Entrepreneur of the Year

Sam-DSC00344-Edit_Web.jpg

Samuel Lynch, DMSc, DMD

Founder / Chairman / CEO

LRM-Logo-FINAL-_Primary.png

Executive Leadership

Finance

Manufacturing

Regulatory

Quality systems

Facial

Skin Rejuvenation / Facial Aesthetics

  • Sales to Aesthetic Providers

  • Marketing

  • Direct Pay

Wound application.jpg

Skin Regeneration / Wound Care

  • Sales to wound care clinics, hospitals, podiatrists

  • Marketing

  • Reimbursement

Our Medical Advisors & Investigators

Technology has been Developed in Collaboration with Scientists from Around the World…

Below are the Clinical Investigators Committed to Performing the Next Clinical Trials

© 2025 Lynch Regenerative Medicine, LLC. All rights reserved. LRM logo, LRM WoundCare and logo design, Regranex and logo design, and ariessence pure PDGF+ and logo design are trademarks of Lynch Regenerative Medicine, LLC. MKT-004 Rev 2.0. 

bottom of page